McKesson misses 3rd-quarter revenue estimates
S&P Global Ratings has revised its outlook on McKesson Corp (NYSE:MCK). to positive from stable, while affirming its 'BBB+' ...
The stock's fall snapped a three-day winning streak.
Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...
Citi analyst Daniel Grosslight increased the price target for McKesson Corporation (NYSE:MCK) shares to $685 from $677 while ...
Mizuho Securities analyst Steven Valiquette maintained a Hold rating on McKesson (MCK – Research Report) yesterday and set a price target of ...
Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...
McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...
McKesson (MCK) and AmerisourceBergen (ABC) are among the pharmaceutical wholesalers that have won a bid to dismiss antitrust allegations that ...
McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback